(Q36658985)

15 August 2017

1 reference

title

Hypophosphatemic rickets and osteomalacia (English)

1 reference

15 August 2017

Hamilton de Menezes Filho

series ordinal

1

1 reference

PubMed ID

17117305

15 August 2017

Luiz Claudio G de Castro

series ordinal

2

1 reference

PubMed ID

17117305

15 August 2017

Durval Damiani

series ordinal

3

1 reference

15 August 2017

1 August 2006

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

15 August 2017

1 reference

15 August 2017

50

1 reference

15 August 2017

4

1 reference

15 August 2017

802-813

1 reference

The wrickkened pathways of FGF23, MEPE and PHEX.

15 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Evidence for a bone-kidney axis regulating phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Prevalence of vitamin D deficiency among healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

The molecular background to hypophosphataemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

A clinical and molecular genetic study of hypophosphatemic rickets in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Renal phosphate loss in hereditary and acquired disorders of bone mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: implications for correct diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

"Phosphatonins" and the regulation of phosphorus homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Characterization of the human type II Na/Pi-cotransporter promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

The sodium phosphate cotransporter family SLC34

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Molecular mechanisms of renal apical Na/phosphate cotransport

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

FGF23 is processed by proprotein convertases but not by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Oncogenic osteomalacia--a complex dance of factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Dental alterations associated with X-linked hypophosphatemic rickets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302006000400025

10.1590/S0004-27302006000400025

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17117305